JPWO2020176738A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020176738A5
JPWO2020176738A5 JP2021550218A JP2021550218A JPWO2020176738A5 JP WO2020176738 A5 JPWO2020176738 A5 JP WO2020176738A5 JP 2021550218 A JP2021550218 A JP 2021550218A JP 2021550218 A JP2021550218 A JP 2021550218A JP WO2020176738 A5 JPWO2020176738 A5 JP WO2020176738A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
human subject
administration
once
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021550218A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022523530A (ja
JP2022523530A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/020115 external-priority patent/WO2020176738A1/en
Publication of JP2022523530A publication Critical patent/JP2022523530A/ja
Publication of JP2022523530A5 publication Critical patent/JP2022523530A5/ja
Publication of JPWO2020176738A5 publication Critical patent/JPWO2020176738A5/ja
Abandoned legal-status Critical Current

Links

JP2021550218A 2019-02-28 2020-02-27 化膿性汗腺炎の治療のための抗IL-α抗体 Abandoned JP2022523530A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962811696P 2019-02-28 2019-02-28
US62/811,696 2019-02-28
PCT/US2020/020115 WO2020176738A1 (en) 2019-02-28 2020-02-27 Anti-il-alpha antibody for the treatment of hidradenitis suppurativa

Publications (3)

Publication Number Publication Date
JP2022523530A JP2022523530A (ja) 2022-04-25
JP2022523530A5 JP2022523530A5 (https=) 2023-03-01
JPWO2020176738A5 true JPWO2020176738A5 (https=) 2023-03-01

Family

ID=70110308

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021550218A Abandoned JP2022523530A (ja) 2019-02-28 2020-02-27 化膿性汗腺炎の治療のための抗IL-α抗体

Country Status (11)

Country Link
US (1) US20200277370A1 (https=)
EP (1) EP3930752A1 (https=)
JP (1) JP2022523530A (https=)
KR (1) KR20210134927A (https=)
CN (1) CN113905760A (https=)
AU (1) AU2020228299A1 (https=)
BR (1) BR112021016845A2 (https=)
CA (1) CA3131011A1 (https=)
MX (1) MX2021010402A (https=)
TW (1) TW202045537A (https=)
WO (1) WO2020176738A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102167261B1 (ko) 2010-06-18 2020-10-20 엑스바이오테크, 인크. 관절염 치료
CA3095740A1 (en) 2020-10-07 2022-04-07 Xbiotech Inc. True human antibody specific for interleukin alpha (il-1a)
CA3095675A1 (en) 2020-10-07 2022-04-07 Xbiotech Inc. True human antibody specific for interleukin 1 alpha (il-1a)
CA3095676A1 (en) * 2020-10-07 2022-04-07 Xbiotech Inc. True human antibody specific for interleukin 1 alpha (il-1a)
CA3095679A1 (en) 2020-10-07 2022-04-07 Xbiotech Inc. True human antibody specific for interleuken 1 alpha (il-1a)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2726345C (en) 2008-05-30 2018-08-28 John Simard Interleukin-1 alpha antibodies and methods of use
JP5812669B2 (ja) 2011-04-27 2015-11-17 キヤノン株式会社 画像処理装置および画像処理方法およびコンピュータプログラム。
ES2688821T3 (es) 2012-11-02 2018-11-07 Repros Therapeutics Inc. Métodos y composiciones para tratar afecciones dependientes de la progesterona
KR101753553B1 (ko) 2014-06-03 2017-07-03 엑스바이오테크, 인크. 스타필로코커스 아우레우스 감염의 치료 및 예방을 위한 조성물 및 방법
CA3053231A1 (en) * 2017-02-16 2018-08-23 Xbiotech Inc. Treatment of hidradenitis suppurativa

Similar Documents

Publication Publication Date Title
JP2022188083A5 (https=)
JP2024075713A5 (https=)
JP2020507587A5 (https=)
RU96101193A (ru) Фрагменты антител в терапии
JP2003531129A5 (https=)
JP2024001125A (ja) Il-17アンタゴニストを用いて初発プラーク型乾癬を治療する方法
ÖzDEMIR et al. A randomized comparison of acitretin-narrow-band TL-01 phototherapy and acitretin-psoralen plus ultraviolet A for psoriasis
JP2017511316A5 (https=)
Karageorgaki et al. Infliximab in Takayasu arteritis: a safe alternative?
JP2019521156A5 (https=)
WO2023061472A1 (zh) 抗her2抗体药物偶联物和酪氨酸激酶抑制剂联合在制备治疗肿瘤的药物中的用途
US20230331834A1 (en) Method of treating tendinopathy using interleukin-17 (il-17)
TW202045537A (zh) 化膿性汗腺炎的治療
JP2021532176A5 (https=)
JPWO2020176738A5 (https=)
KR20180017145A (ko) 소양증의 치료
JP2014510748A5 (https=)
JP7410256B2 (ja) 化膿性汗腺炎の治療のための汎elr+cxcケモカイン抗体
US5716646A (en) Methods and compositions for treating arthritis
WO2024112527A3 (en) Methods for the treatment of thyroid eye disease
JPWO2020234781A5 (https=)
JP2004514698A (ja) P物質の投与を含む治療方法
RU2019108441A (ru) Режим дозирования
RU2382638C1 (ru) Способ лечения псориаза
JPS5821624A (ja) 慢性関節リウマチの治療剤